Outsourcing vs. Insourcing in Biopharma: Determining the Best Strategy Drug Solutions

In what instances should organizations outsource vs. insource? Determining the right outsourcing strategy is key to limit unnecessary costs, maintain output and turnaround times, and enable continued flexibility. Meg Rivers, senior editor for Pharmaceutical Technology, and John Koleng, VP of product development and manufacturing for TFF Pharmaceuticals, will discuss: 1) what the biopharma industry currently tends to outsource, 2) outsourcing strategies the biopharma industry should be utilizing, 3) internal tasks the biopharma industry should consider outsourcing more in development and manufacturing, 4) what the biopharma industry should reconsider outsourcing and instead perform in-house, and 5) what organizations are choosing not to outsource and why.

SPONSORS: Curia